NDC 69364-3143

Naltrexone

Naltrexone

Naltrexone is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Complete Pharmacy And Medical Solutions. The primary component is Naltrexone; Triamcinolone.

Product ID69364-3143_7b0350b5-ca48-4aef-8b10-ebd9f51967d0
NDC69364-3143
Product TypeHuman Prescription Drug
Proprietary NameNaltrexone
Generic NameNaltrexone
Dosage FormImplant
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2018-02-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameComplete Pharmacy and Medical Solutions
Substance NameNALTREXONE; TRIAMCINOLONE
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesOpioid Antagonist [EPC],Opioid Antagonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 69364-3143-6

6 BLISTER PACK in 1 BOX (69364-3143-6) > 1 IMPLANT in 1 BLISTER PACK
Marketing Start Date2018-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69364-3143-6 [69364314306]

Naltrexone IMPLANT
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-02-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
NALTREXONE200 mg/1

OpenFDA Data

SPL SET ID:40b16844-bc1c-485e-aad3-2cb86e2eb009
Manufacturer
UNII

Pharmacological Class

  • Opioid Antagonist [EPC]
  • Opioid Antagonists [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

NDC Crossover Matching brand name "Naltrexone" or generic name "Naltrexone"

NDCBrand NameGeneric Name
69364-3143Naltrexonenaltrexone
65757-300VIVITROLnaltrexone
65757-301VIVITROLnaltrexone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.